Depression and Nigral Neuron Density in Lewy Body Spectrum Diseases

Ann Neurol. 2021 May;89(5):1046-1050. doi: 10.1002/ana.26046. Epub 2021 Mar 3.

Abstract

Parkinson's disease and other Lewy body spectrum diseases (LBDs) are associated with a specific risk for clinical depression. In the present clinicopathological study with 73 patients with LBD, we observed that the substantia nigra pars compacta dopamine neuron density was markedly lower in patients who had comorbid depression antemortem than in nondepressed patients (1.52 vs 2.32 n/mm2 , p = 0.004). There were no differences in cognition, motor disease severity, antiparkinsonian medications, or disease duration between groups. The results implicate the substantia nigra as an important psychomotor modulatory area of mood in patients with Lewy body disorders. ANN NEUROL 2021;;89:1046-1050.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Autopsy
  • Cell Count
  • Depression / etiology
  • Depression / psychology*
  • Dopaminergic Neurons / pathology*
  • Female
  • Humans
  • Lewy Body Disease / complications
  • Lewy Body Disease / pathology*
  • Lewy Body Disease / psychology*
  • Male
  • Mental Status and Dementia Tests
  • Neuropsychological Tests
  • Substantia Nigra / pathology*